GW Pharmaceuticals PLC Holding(s) in Company (3782I)
May 29 2014 - 9:11AM
UK Regulatory
TIDMGWP
RNS Number : 3782I
GW Pharmaceuticals PLC
29 May 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
--------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals plc
issuer
of existing shares to which voting rights
are
attached:
-------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------- -------
Other (please
specify):
------------------ --------------------------------------------------------- -------
3. Full name of person(s) subject The Capital Group Companies, Inc.
to the
notification obligation:
------------------------------------------ ------------------------------------------
4. Full name of shareholder(s) Holdings by CG Management Companies
(if different from 3.): and Funds
------------------------------------------ ------------------------------------------
5. Date of the transaction and date 27 May 2014
on
which the threshold is crossed
or
reached:
------------------------------------------ ------------------------------------------
6. Date on which issuer notified: 28 May 2014
------------------------------------------ ------------------------------------------
7. Threshold(s) that is/are crossed Above 5%
or
reached:
------------------------------------------ ------------------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
-----------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights
Shares Voting shares
Rights
--------------------- ------------- ------------------- --------- ----------------------- ------------------------------
Direct Direct Indirect Direct Indirect
--------------------- --- ------ ------ ----- ---- --------- ---------- ----------- ------------- ---------------
ADRs
(ISIN: US36197T1034) 888,100 10,657,200 10,866,000 5.0169%
--------------------- ------------- ------------------- --------- ---------- ----------- ------------- ---------------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/ converted.
---------------------------- -------------- --------------------------- --------------------------- ---------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
-----------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date Conversion rights instrument
period refers to
----------------------- ----------- ------------- --------------- --------------------------- --------------------------
Nominal Delta
----------------------- ----------- ------------- --------------- --------------------------- ------------ ------------
Total (A+B+C)
-----------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------------ ---------------------------------------------------------
10,866,000 5.0169%
------------------------------------------------------------------ ---------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------
Holdings by CG Management Companies and Funds
Capital Research and Management Company
SMALLCAP World Fund, Inc
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Christopher Aquino
---------------------------------------- --------------------------------------
15. Contact telephone number: (213) 615 0469
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEALSNAEPLEFF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles